Skip to main content

Month: May 2022

NIO Inc. Announces Proposed Secondary Listing on the Singapore Exchange

SHANGHAI, China, May 05, 2022 (GLOBE NEWSWIRE) — NIO Inc. (NYSE: NIO; HKEX: 9866) (“NIO” or the “Company”), a pioneer and a leading company in the premium smart electric vehicle market, today announced the proposed secondary listing of its Class A ordinary shares, par value US$0.00025 per share (the “Shares”), by way of introduction on the Main Board of the Singapore Exchange Securities Trading Limited (the “SGX-ST”). The Company’s American depositary shares (the “ADSs”), each representing one Share, will continue to be primarily listed and traded on the New York Stock Exchange (the “NYSE”). The Company has received a conditional eligibility-to-list letter (“ETL”) from the SGX-ST on May 5, 2022 for the listing and quotation of the Shares on the Main Board of the SGX-ST. The ETL is not an indication of the merits of the proposed...

Continue reading

Immuron appoints Mr. Steven Lydeamore as Chief Executive Officer

MELBOURNE, Australia, May 05, 2022 (GLOBE NEWSWIRE) — Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral immunotherapeutics for the prevention and treatment of gut mediated pathogens, is pleased to announce the appointment of Steven Lydeamore as Chief Executive Officer (CEO) of the Company effective 27 June 2022. Mr. Lydeamore has 30 years international pharmaceutical experience, working in Australia, Canada and USA. Mr. Lydeamore brings valuable international experience having spent eleven years working at Canadian global pharmaceutical company Apotex Inc., and four years for Mayne Pharma (USA) Limited. This includes valuable experience in mergers and acquisitions, finance, business development, sales and marketing, manufacturing, and research and development....

Continue reading

Scilex, a Sorrento Company, Announces Pivotal Phase 3 SP-102 (SEMDEXA™) Data Presentation At The American Society Of Interventional Pain (ASIPP) 2022 Annual Meeting

SP-102 (SEMDEXATM) is the first non-opioid novel injectable corticosteroid gel formulation product in development for the treatment of lumbar radicular pain, and it contains no preservatives, surfactants, solvents, or particulates. The study met its primary endpoint with a highly statistically significant reduction in average daily leg pain in patients receiving SEMDEXATM compared to placebo (p

Continue reading

Cartesian Growth Corporation II Announces Pricing of $200 Million Initial Public Offering

New York, NY, May 05, 2022 (GLOBE NEWSWIRE) — Cartesian Growth Corporation II (the “Company”) announced today the pricing of its initial public offering of 20,000,000 units at a price of $10.00 per unit. The units are expected to commence trading on May 6, 2022 on the Nasdaq Global Market under the symbol “RENEU”. The Company’s sponsor is an affiliate of Cartesian Capital Group, LLC, a global private equity firm specializing in providing growth capital to transnational businesses.  Each unit consists of one Class A ordinary share and one-third of one redeemable warrant, with each whole warrant entitling the holder to purchase one Class A ordinary share at a price of $11.50 per share. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on the Nasdaq...

Continue reading

NMHC Names Toll Brothers Apartment Living® One of the Largest Multifamily Developers in the United States

Toll Brothers Apartment Living is Ranked #11 Nationwide with 3,621 Units Started in 2021Ferro Plano, TXFORT WASHINGTON, Pa., May 05, 2022 (GLOBE NEWSWIRE) — Toll Brothers Apartment Living®, the rental division of Toll Brothers, Inc. (NYSE: TOL), the nation’s leading builder of luxury homes, has been named one of the largest multifamily developers in the United States by the National Multifamily Housing Council’s (NMHC) 2022 NMHC 50, the annual ranking of the nation’s largest apartment owners, managers, developers, builders, and syndicators. Toll Brothers Apartment Living is now ranked as the 11th largest multifamily developer in the United States, with 3,621 units started during the year of 2021. “We’re extremely honored to earn the recognition as one of the top multifamily developers nationwide,” said Charles Elliott, President...

Continue reading

IDT Corporation Postpones Spinoff of net2phone

NEWARK, NJ, May 05, 2022 (GLOBE NEWSWIRE) — IDT Corporation (NYSE: IDT), a global provider of fintech, cloud communications, and traditional communications services, announced today that, in light of current market conditions, its Board of Directors has postponed the spinoff of its net2phone cloud communications segment, which it had been preparing to spin off on or before July 31st, 2022. “The net2phone team has achieved exceptional results bringing advanced cloud communication solutions to markets in North and South America,” said Jonah Fink, President of net2phone. “We remain very excited by net2phone’s rapid growth, the transformational opportunities created through the recent acquisition of Integra, and the strength of net2phone’s global channel partnerships.” Shmuel Jonas, IDT’s CEO, added, “While net2phone remains within...

Continue reading

CORRECTION – Celyad Oncology Announces First Quarter 2022 Financial Results and Recent Business Highlights

MONT-SAINT-GUIBERT, Belgium, May 05, 2022 (GLOBE NEWSWIRE) — In a release issued under the same headline earlier today by Celyad Oncology SA (Euronext & Nasdaq: CYAD), please note that in the First Quarter 2022 Financial Review section, the figures for cash and cash equivalents and net cash burn during the first quarter of 2022 should have been stated as €20.5 million ($22.9 million) and €9.5 million ($10.6 million), respectively, not €20.6 million ($23.0 million) and €9.4 million ($10.5 million), respectively. The corrected release follows:Enrollment continues in Phase 1 dose-escalation IMMUNICY-1 trial for lead shRNA-based allogeneic CAR T candidate, CYAD-211, for relapsed/refractory multiple myeloma (r/r MM) Dialogue continues with regulatory agencies concerning CYAD-101-002 Phase 1b trial, which remains on clinical holdCelyad...

Continue reading

Melcor REIT announces first quarter 2022 results

EDMONTON, Alberta, May 05, 2022 (GLOBE NEWSWIRE) —Highlights (compared to Q1-2021)  First Quarter Results:   Results, excluding Early Termination event1:Revenue was down 3% at $18.97 million. Net operating income (NOI) was down 6% to $11.86 million. Funds from operation (FFO) was down 8% to $6.53 million or $0.22 per unit. Adjusted cash from operations (ACFO) was stable at $5.77 million or $0.20 per unit. Occupancy was up slightly at 87.4%. Distributions of $0.04 per unit were paid in January through March for a ACFO payout ratio of 61%. Revenue was up 3%. NOI was up 2%. FFO was up 7% or $0.43 million.Early Termination event: In the comparative quarter, we received $1.00 million for the early lease termination of a fast food chain occupying 6,384 sf in Leduc Common.     Melcor REIT (TSX: MR.UN) today...

Continue reading

Acreage Holdings Reports First Quarter 2022 Financial Results

Achieved 5th consecutive quarter of positive Adjusted EBITDA* Consolidated revenue increased 48% year-over-year to $57 million in the first quarter Remodeled House of Brands portfolio with the launch of craft brand Superflux in three markets and expansion of The Botanist product line NEW YORK, May 05, 2022 (GLOBE NEWSWIRE) — Acreage Holdings, Inc. (“Acreage” or the “Company”) (CSE:ACRG.A.U, ACRG.B.U), (OTCQX: ACRHF, ACRDF), a vertically integrated, multi-state operator of cannabis cultivation and retailing facilities in the U.S., today reported its financial results for the first quarter ended March 31, 2022 (“Q1 2022”). First Quarter 2022 Financial HighlightsConsolidated revenue was $56.9 million for Q1 2022, an increase of 48% year-over-year. Gross margin of 52% compared to 48% in Q4 2021, and 54% in Q1 2021. Adjusted EBITDA*...

Continue reading

FAX Capital Corp. Announces Filing of First Quarter 2022 Results

NOT FOR DISSEMINATION IN THE UNITED STATES OR DISTRIBUTION TO U.S. NEWS WIRE SERVICES TORONTO, May 05, 2022 (GLOBE NEWSWIRE) — FAX Capital Corp. (the Company) (TSX: FXC) announces that it has filed its financial results for the first quarter ended March 31, 2022. The Company’s Financial Statements and Management’s Discussion & Analysis for the quarter are available under the Company’s profile at www.sedar.com and www.faxcapitalcorp.com. About FAX Capital Corp. The Company is an investment holding company with a business objective to maximize its intrinsic value on a per share basis over the long-term by seeking to achieve superior investment performance commensurate with reasonable risk. The Company intends to invest in equity, debt and/or hybrid securities of high-quality businesses. The Company initially intends to invest...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.